Urethritis
The EAU 2026 urethritis pathway — confirm urethral inflammation with point-of-care diagnostics, classify gonococcal (GU) versus non-gonococcal (NGU) urethritis on the Gram stain, test with NAAT before treating, give empirical then pathogen-directed antibiotics, and manage sexual partners with a test of cure and a route for persistent or recurrent NGU. New in 2026: whether to treat empirically now or defer for the NAAT no longer turns on the GU/NGU split but on the clinical picture — objective findings, distress, exposure and follow-up availability. Switch between the visual Pathway map and the phase-by-phase Explorer.
Study reference — verify against current EAU guidelines before clinical use. Dashed amber = weak recommendation; dashed taupe = no formal recommendation.